{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:01:34Z","timestamp":1767142894763,"version":"build-2238731810"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["JSPS19K08695"],"award-info":[{"award-number":["JSPS19K08695"]}]},{"name":"JST","award":["JPMJPF2017"],"award-info":[{"award-number":["JPMJPF2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although SARS-CoV-2 vaccines, particularly mRNA-based formulations, have demonstrated high efficacy and safety, adverse events including autoimmune activity have been reported. We report a case of systemic lupus erythematosus (SLE) following SARS-CoV-2 vaccination in a 52-year-old Japanese female with autosomal dominant polycystic kidney disease (ADPKD). The patient presented with nephrotic syndrome and severe thrombocytopenia and fulfilled the following four criteria for SLE classification: positive antinuclear antibodies, positive anti-ds-DNA antibodies, renal involvement, and reductions in two blood cell lines (leukopenia and thrombocytopenia). The patient responded favorably to prednisolone therapy, although hydroxychloroquine was avoided because of a suspected allergic predisposition. This case underscores the potential for exogenous triggers such as vaccination to induce SLE, highlighting the need for vigilance in managing autoimmune responses, particularly in patients with chronic conditions such as ADPKD. Despite the patient\u2019s history of ADPKD, no previous reports have linked this condition to post-vaccine SLE. Concurrent nephrotic syndrome in patients with ADPKD is rare, and the possibility of other treatable glomerular diseases should be considered when this is seen.<\/jats:p>","DOI":"10.1007\/s13730-025-00999-y","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:23:39Z","timestamp":1747740219000},"page":"679-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARS-CoV-2 vaccination"],"prefix":"10.1007","volume":"14","author":[{"given":"Kensuke","family":"Miyauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joichi","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-819X","authenticated-orcid":false,"given":"Hirayasu","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"27","key":"999_CR1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"issue":"20","key":"999_CR2","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N Engl J Med. 2020;383(20):1920\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2022483.","journal-title":"N Engl J Med"},{"key":"999_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1172\/jci.insight.149187","volume":"6","author":"JL Golob","year":"2021","unstructured":"Golob JL, Lugogo N, Lauring AS, Lok AS. SARS-CoV-2 vaccines: a triumph of science and collaboration. JCI Insight. 2021;6:9. https:\/\/doi.org\/10.1172\/jci.insight.149187.","journal-title":"JCI Insight."},{"key":"999_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.876336","volume":"10","author":"S Ganesan","year":"2022","unstructured":"Ganesan S, Al Ketbi LMB, Al Kaabi N, Al Mansoori M, Al Maskari NN, Al Shamsi MS, et al. Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study. Front Public Health. 2022;10: 876336. https:\/\/doi.org\/10.3389\/fpubh.2022.876336.","journal-title":"Front Public Health"},{"key":"999_CR5","doi-asserted-by":"publisher","DOI":"10.2196\/51007","volume":"10","author":"Y Li","year":"2024","unstructured":"Li Y, Li J, Dang Y, Chen Y, Tao C. Adverse events of COVID-19 vaccines in the United States: temporal and spatial analysis. JMIR Public Health Surveill. 2024;10: e51007. https:\/\/doi.org\/10.2196\/51007.","journal-title":"JMIR Public Health Surveill"},{"issue":"3","key":"999_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.807","volume":"11","author":"F Yasmin","year":"2023","unstructured":"Yasmin F, Najeeb H, Naeem U, Moeed A, Atif AR, Asghar MS, et al. Adverse events following COVID-19 mRNA vaccines: a systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023;11(3): e807. https:\/\/doi.org\/10.1002\/iid3.807.","journal-title":"Immun Inflamm Dis"},{"key":"999_CR7","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2147\/dddt.S464394","volume":"18","author":"LD Panos","year":"2024","unstructured":"Panos LD, Bargiotas P, Hadjigeorgiou G, Panos GD. Neurovascular adverse effects of Sars-Cov-2 vaccination. Drug Des Devel Ther. 2024;18:1891\u2013905. https:\/\/doi.org\/10.2147\/dddt.S464394.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"999_CR8","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s00296-022-05203-3","volume":"42","author":"I Sagy","year":"2022","unstructured":"Sagy I, Zeller L, Raviv Y, Porges T, Bieber A, Abu-Shakra M. New-onset systemic lupus erythematosus following BNT162b2 mRNA COVID-19 vaccine: a case series and literature review. Rheumatol Int. 2022;42(12):2261\u20136. https:\/\/doi.org\/10.1007\/s00296-022-05203-3.","journal-title":"Rheumatol Int"},{"issue":"4","key":"999_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10165-012-0733-7","volume":"23","author":"A Ohta","year":"2013","unstructured":"Ohta A, Nagai M, Nishina M, Tomimitsu H, Kohsaka H. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis\/dermatomyositis, and systemic sclerosis in Japan. Mod Rheumatol. 2013;23(4):759\u201364. https:\/\/doi.org\/10.1007\/s10165-012-0733-7.","journal-title":"Mod Rheumatol"},{"issue":"4","key":"999_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.kint.2022.01.013","volume":"101","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Jung M, Lim BJ, Han SH. New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination. Kidney Int. 2022;101(4):826\u20138. https:\/\/doi.org\/10.1016\/j.kint.2022.01.013.","journal-title":"Kidney Int"},{"issue":"6","key":"999_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.kint.2018.06.025","volume":"94","author":"EK Kleczko","year":"2018","unstructured":"Kleczko EK, Marsh KH, Tyler LC, Furgeson SB, Bullock BL, Altmann CJ, et al. CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression. Kidney Int. 2018;94(6):1127\u201340. https:\/\/doi.org\/10.1016\/j.kint.2018.06.025.","journal-title":"Kidney Int"},{"key":"999_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/jci.insight.161318","volume":"8","author":"EK Kleczko","year":"2023","unstructured":"Kleczko EK, Nguyen DT, Marsh KH, Bauer CD, Li AS, Monaghan MT, et al. Immune checkpoint activity regulates polycystic kidney disease progression. JCI Insight. 2023;8:12. https:\/\/doi.org\/10.1172\/jci.insight.161318.","journal-title":"JCI Insight."},{"issue":"2","key":"999_CR13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000187043","volume":"62","author":"P Tudela","year":"1992","unstructured":"Tudela P, Mart\u00ed S, Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 1992;62(2):236. https:\/\/doi.org\/10.1159\/000187043.","journal-title":"Nephron"},{"issue":"13","key":"999_CR14","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/0961203309345732","volume":"18","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin N, Zafrir Y, Paz Z, Shilton T, Zandman-Goddard G, Shoenfeld Y. Ten cases of systemic lupus erythematosus related to hepatitis B vaccine. Lupus. 2009;18(13):1192\u20137. https:\/\/doi.org\/10.1177\/0961203309345732.","journal-title":"Lupus"},{"issue":"2","key":"999_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/0961203311429556","volume":"21","author":"HF Soldevilla","year":"2012","unstructured":"Soldevilla HF, Briones SF, Navarra SV. Systemic lupus erythematosus following HPV immunization or infection? Lupus. 2012;21(2):158\u201361. https:\/\/doi.org\/10.1177\/0961203311429556.","journal-title":"Lupus"},{"key":"999_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108765","volume":"229","author":"PA Ntouros","year":"2021","unstructured":"Ntouros PA, Vlachogiannis NI, Pappa M, Nezos A, Mavragani CP, Tektonidou MG, et al. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus systemic lupus erythematosus. Clin Immunol. 2021;229: 108765. https:\/\/doi.org\/10.1016\/j.clim.2021.108765.","journal-title":"Clin Immunol"},{"key":"999_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/ijms23052505","volume":"23","author":"TM Sim","year":"2022","unstructured":"Sim TM, Ong SJ, Mak A, Tay SH. Type I interferons in systemic lupus erythematosus: a journey from bench to bedside. Int J Mol Sci. 2022;23:5. https:\/\/doi.org\/10.3390\/ijms23052505.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"999_CR18","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.kint.2021.09.009","volume":"100","author":"MF Zavala-Miranda","year":"2021","unstructured":"Zavala-Miranda MF, Gonz\u00e1lez-Ibarra SG, P\u00e9rez-Arias AA, Uribe-Uribe NO, Mejia-Vilet JM. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination. Kidney Int. 2021;100(6):1340\u20131. https:\/\/doi.org\/10.1016\/j.kint.2021.09.009.","journal-title":"Kidney Int"},{"key":"999_CR19","doi-asserted-by":"publisher","first-page":"6436839","DOI":"10.1155\/2022\/6436839","volume":"2022","author":"L B\u00e1ez-Negr\u00f3n","year":"2022","unstructured":"B\u00e1ez-Negr\u00f3n L, Vil\u00e1 LM. New-onset systemic lupus erythematosus after mRNA SARS-CoV-2 vaccination. Case Rep Rheumatol. 2022;2022:6436839. https:\/\/doi.org\/10.1155\/2022\/6436839.","journal-title":"Case Rep Rheumatol"},{"issue":"5","key":"999_CR20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s10067-022-06097-z","volume":"41","author":"AM N","year":"2022","unstructured":"N AM, Saleh AM, Khalid A, Alshaya AK, Alanazi SMM. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review. Clin Rheumatol. 2022;41(5):1577\u201382. https:\/\/doi.org\/10.1007\/s10067-022-06097-z.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"999_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/qjmed\/hcab229","volume":"114","author":"A Nune","year":"2021","unstructured":"Nune A, Iyengar KP, Ish P, Varupula B, Musat CA, Sapkota HR. The emergence of new-onset SLE following SARS-CoV-2 vaccination. QJM. 2021;114(10):739\u201340. https:\/\/doi.org\/10.1093\/qjmed\/hcab229.","journal-title":"QJM"},{"issue":"10","key":"999_CR22","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/jocd.14386","volume":"20","author":"S Patil","year":"2021","unstructured":"Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: a case report. J Cosmet Dermatol. 2021;20(10):3103\u20134. https:\/\/doi.org\/10.1111\/jocd.14386.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"999_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/ndtplus\/sfn197","volume":"2","author":"RK Wan","year":"2009","unstructured":"Wan RK, Kipgen D, Morris S, Rodger RS. A rare cause of nephrotic syndrome in autosomal-dominant polycystic kidney disease. NDT Plus. 2009;2(2):136\u20138. https:\/\/doi.org\/10.1093\/ndtplus\/sfn197.","journal-title":"NDT Plus"},{"issue":"2","key":"999_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/1596-3519.179735","volume":"15","author":"AA Akinbodewa","year":"2016","unstructured":"Akinbodewa AA, Adejumo OA, Ogunsemoyin AO, Osasan SA, Adefolalu OA. Co-existing autosomal dominant polycystic kidney disease and nephrotic syndrome in a Nigerian patient with lupus nephritis. Ann Afr Med. 2016;15(2):83\u20136. https:\/\/doi.org\/10.4103\/1596-3519.179735.","journal-title":"Ann Afr Med"},{"issue":"3","key":"999_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.krcp.2012.06.002","volume":"31","author":"JI Park","year":"2012","unstructured":"Park JI, Lee H, An JN, Chin HJ, Kim S. Laparoscopic biopsy-proven lupus nephritis in autosomal dominant polycystic kidney disease. Kidney Res Clin Pract. 2012;31(3):192\u20135. https:\/\/doi.org\/10.1016\/j.krcp.2012.06.002.","journal-title":"Kidney Res Clin Pract"}],"updated-by":[{"DOI":"10.1007\/s13730-025-01021-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000}}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-00999-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-00999-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-00999-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:04:51Z","timestamp":1758719091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-00999-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["999"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-00999-y","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13730-025-01021-1","URL":"https:\/\/doi.org\/10.1007\/s13730-025-01021-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Written informed consent to publish the case (concerning personal or clinical details to be published in this case report) was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}